ストックスクリーナーアプリを入手
0.518
1.07%
0.0055
アフターアワーズ：
.55
0.032
+6.18%
前日終値:
$0.5125
開ける：
$0.55
24時間の取引高:
547.13K
Relative Volume:
0.14
時価総額：
$14.68M
収益：
-
当期純損益:
$-1.29M
株価収益率:
-11.31
EPS:
-0.0458
ネットキャッシュフロー:
$-9.72M
1週間 パフォーマンス:
+15.11%
1か月 パフォーマンス:
+64.18%
6か月 パフォーマンス:
-23.71%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.49
$0.555
1週間の範囲:
$0.40
$0.5587
52週間の値動き範囲:
$0.262
$9.1796
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
Compare CURX vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CURX
Curanex Pharmaceuticals Inc
|
0.518 | 14.52M | 0 | -1.29M | -9.72M | -0.0458 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Curanex Pharmaceuticals Inc (CURX) 最新ニュース
Top Curanex Pharmaceuticals (CURX) Competitors 2026 - MarketBeat
What's Behind Curanex Pharmaceuticals (CURX) 56% Surge After Hours - MSN
Nasdaq tumbles over 350 points; US initial jobless claims increase - MSN
Curanex Pharmaceuticals IncTargets Ind Submission For Phyto-N In Q4 2026 - TradingView
Botanical drug used in China for 30 years clears key U.S. safety test - Stock Titan
Curanex adds two pharmaceutical veterans to advisory board By Investing.com - Investing.com Nigeria
CURANEX PHARMACEUTICALS INC (CURX) Fundamental Analysis & Valuation - ChartMill
Curanex adds two advisors to scientific board ahead of IND filing By Investing.com - Investing.com India
Curanex adds two advisors to scientific board ahead of IND filing - Investing.com Australia
Curanex Expands Scientific Advisory Board With Two Distinguished Researchers - Bitget
TB and COVID scientists join Curanex board to steer 2026 trial plans - Stock Titan
Curanex adds two pharmaceutical veterans to advisory board - Investing.com India
Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board - marketscreener.com
Veteran drug creators with HIV, HCV medicines join Curanex - Stock Titan
Curanex Formalizes Long-Term Executive Employment and Compensation Agreements - TipRanks
Curanex Pharmaceuticals Inc Enters into Executive Employment Agreement with Jun Liu as President and Chairman of the Board, Effective March 1, 2026 - marketscreener.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Curanex Forms World Class Scientific Advisory Board - Bitget
Botanical drug firm Curanex taps Fortune 100 pharma exec to guide R&D - Stock Titan
Curanex Pharmaceuticals Inc (CURX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Stocks in the News: ALBT, NDRA, CURX, HCTIAI, Clinical Milestones Drive Market Surges - marketscreener.com
Market Movers | Winners: IXHL, ALBT, RXT | Losers: THRY, EOSE, ERII - Trefis
Thursday's session: most active stocks - ChartMill
Unusual volume stocks are being observed in Thursday's session. - ChartMill
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Curanex Pharmaceuticals Stock Soars 56.32% After Key IND Milestone - Intellectia AI
24,000,000 Common Stock of Curanex Pharmaceuticals Inc are subject to a Lock-Up Agreement Ending on 26-FEB-2026. - marketscreener.com
Top movers in Wednesday's after hours session - ChartMill
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Curanex completes GMP pilot batch for ulcerative colitis drug - Investing.com
Curanex Completes GMP Pilot For Phyto-N, Targets IND Submission In Ulcerative Colitis - Nasdaq
Curanex provides operational update on key regulatory milestones - marketscreener.com
Curanex completes GMP pilot batch for ulcerative colitis drug By Investing.com - Investing.com South Africa
Curanex Provides Operational Update on Key Regulatory Milestones - GlobeNewswire
Comparing Curanex Pharmaceuticals (CURX) & The Competition - Defense World
Curanex Pharmaceuticals (CURX) versus Its Peers Financial Survey - Defense World
Financial Contrast: Curanex Pharmaceuticals (CURX) & Its Peers - Defense World
Curanex Pharmaceuticals appoints new chief financial officer - MSN
Curanex Pharmaceuticals Inc (CURX) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):